Key result
Nstpbp5185 inhibits platelet aggregation and delays murine thrombus formation with less bleeding than aspirin.
Why the study?
Does nstpbp5185 inhibit platelet aggregation and thrombus formation in preclinical models?
Does nstpbp5185 inhibit platelet aggregation and thrombus formation in preclinical models?
Nstpbp5185 is a novel thromboxane receptor antagonist that demonstrates antiplatelet and antithrombotic efficacy in murine models with potentially less bleeding than aspirin.
Answers are grounded in this paper and cite their sources.
Nstpbp5185 identifies a novel TP antagonist scaffold; hypothesis-generating for antithrombotic therapy with human trials required.
A novel benzimidazole derivative, nstpbp5185, was discovered through in vitro and in vivo evaluations for antiplatelet activity. Thromaboxane receptor (TP) is important in vascular physiology, haemostasis and pathophysiological thrombosis. Nstpbp5185 concentration-dependently inhibited human platelet aggregation caused by collagen, arachidonic acid and U46619. Nstpbp5185 caused a right-shift of the concentration-response curve of U46619 and competitively inhibited the binding of 3H-SQ-29548 to TP receptor expressed on HEK-293 cells, with an IC50 of 0.1 µM, indicating that nstpbp5185 is a TP antagonist. In murine thrombosis models, nstpbp5185 significantly prolonged the latent period in triggering platelet plug formation in mesenteric and FeCl3-induced thrombi formation, and increased the survival rate in pulmonary embolism model with less bleeding than aspirin. This study suggests nstpbp5185, an orally selective anti-thrombotic agent, acting through blockade of TXA2 receptor, may be efficacious for prevention or treatment of pathologic thrombosis.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) studied Thrombosis. nstpbp5185 vs. Aspirin was evaluated on Platelet aggregation and thrombus formation. Nstpbp5185, a novel thromboxane receptor antagonist, inhibited platelet aggregation in vitro and prolonged the latent period of thrombus formation in murine models with less bleeding than aspirin.
Synapse has enriched 10 related papers. Consider them for comparative context: